Moreover, in addition to the direct action of GIP in adipose tissue to reduce serum triglyceride levels, GLP-1 may abolish the postprandial rise in triglyceride and free fatty acid concentrations by reducing intestinal absorption of dietary lipid, stemmed from the delayed gastric emptying (197, 198)
If you are interested in participating in a clinical trial involving retatrutide or other investigational agents, the NIHR Be Part of Research portal (bepartofresearch.nihr.ac.uk) provides information on trials currently recruiting in the UK
Researchers found a 9% reduction in biological aging speed using the DunedinPACE epigenetic clock, alongside improvements in markers linked to mortality risk and age-related disease
Moving beyond food noise to drug noise, GLP-1s are quieting the roar of addiction. Cai M, Choi T, Xie Y, Al-Aly Z
They reduce appetite, slow gastric emptying, increase feelings of fullness and at pharmacological doses produce significant reductions in caloric intake that result in substantial weight loss
However, it is now clear that the portfolio of GLP-1 drugs will remain in shortage for some amount of time and at Hims & Hers, we believe any amount of time is too long to wait for the care you deserve and the treatments you need